Company Name, Ticker, Suppliers, else..

Best Performing Stocks In Biotechnology & Pharmaceuticals Industry During The Last 5 Days

1 Day

Week

Current Month of September

30 Days

Current Quarter Q3 of 2024

90 Days

Ytd

12 Months

Shares are up by 2.25% on average, in Biotechnology & Pharmaceuticals Industry during the last 5 days.

Here are the best performing stocks in Biotechnology & Pharmaceuticals Industry.

ARGX

$551.73

$37.5000

7.29%
Last 5 Days

ARGX

$551.73

$37.5000

7.29%

Argenx se

Argenx Se stock improved 7.29% during the last 5 days.

Argenx is a biopharmaceutical company that utilizes its proprietary antibody discovery platform to develop and commercialize transformative antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Their business model focuses on discovering and developing novel antibodies, partnering with pharmaceutical companies for clinical development, and retaining rights to commercialize the therapies in specific regions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 31,541.992 mill.	$ 2,494.910 mill.	$ -295.053 mill.	57 mill.	-	Y/Y 191.46 %

Market Cap.	Revenues TTM	Net Income TTM
$ 31,541.992 mill.	$ 2,494.910 mill.	$ -295.053 mill.
Employees	Shares Outstanding	P/E
-	57 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 191.46 %	MRQ Y/Y - %

GILD

$79.2

$-0.5000

-0.63%
Last 5 Days

GILD

$79.2

$-0.5000

-0.63%

Gilead Sciences Inc

Gilead Sciences Inc shares declined -0.63% during the last 5 days.

Gilead Sciences Inc*s business model revolves around researching, developing, and commercializing innovative medicines in various therapeutic areas, with a primary focus on antiviral drugs. They aim to address unmet medical needs and improve the lives of patients worldwide.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 99,079.200 mill.	$ 27,805.000 mill.	$ 1,033.000 mill.	1,251 mill.	96.33	Y/Y 5.38 %

Market Cap.	Revenues TTM	Net Income TTM
$ 99,079.200 mill.	$ 27,805.000 mill.	$ 1,033.000 mill.
Employees	Shares Outstanding	P/E
14,400	1,251 mill.	96.33
Revenue Growth	Income Growth
MRQ Y/Y 5.38 %	MRQ Y/Y 55.34 %

AMGN

$324.66

$-5.8500

-1.77%
Last 5 Days

AMGN

$324.66

$-5.8500

-1.77%

Amgen Inc

Amgen Inc stock went down -1.77% during the last 5 days.

Amgen Inc*s business model is centered around developing, manufacturing, and commercializing innovative biotechnology products.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 175,641.060 mill.	$ 30,934.000 mill.	$ 3,130.000 mill.	541 mill.	55.85	Y/Y 20.07 %

Market Cap.	Revenues TTM	Net Income TTM
$ 175,641.060 mill.	$ 30,934.000 mill.	$ 3,130.000 mill.
Employees	Shares Outstanding	P/E
24,200	541 mill.	55.85
Revenue Growth	Income Growth
MRQ Y/Y 20.07 %	MRQ Y/Y -45.90 %

BIIB

$199.14

$-5.7000

-2.78%
Last 5 Days

BIIB

$199.14

$-5.7000

-2.78%

Biogen Inc

Biogen Inc shares declined -2.78% during the last 5 days.

Biogen Inc*s business model revolves around researching, developing, and commercializing therapies for neurological and neurodegenerative diseases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 29,054.526 mill.	$ 9,672.000 mill.	$ 1,157.600 mill.	146 mill.	25.11	Y/Y 0.36 %

Market Cap.	Revenues TTM	Net Income TTM
$ 29,054.526 mill.	$ 9,672.000 mill.	$ 1,157.600 mill.
Employees	Shares Outstanding	P/E
9,610	146 mill.	25.11
Revenue Growth	Income Growth
MRQ Y/Y 0.36 %	MRQ Y/Y -1.63 %